Market Overview - U.S. stocks traded higher, with the Dow Jones index gaining over 250 points, up 0.54% to 48,641.58, NASDAQ up 0.65% to 23,386.57, and S&P 500 up 0.63% to 6,901.52 [1] - Energy shares increased by 2.9% on Monday [1] Sector Performance - Consumer staples stocks dipped by 0.4% [2] Commodity Prices - Oil traded up 1.4% to $58.12, gold up 2.4% to $4,433.50, silver up 7.5% to $76.320, and copper rose 4.1% to $5.9260 [5] European Market Performance - European shares were higher, with the eurozone's STOXX 600 gaining 0.5%, Spain's IBEX 35 Index up 0.3%, London's FTSE 100 up 0.4%, Germany's DAX up 0.2%, and France's CAC 40 up 0.1% [6] Asian Market Performance - Asian markets closed mostly higher, with Japan's Nikkei 225 gaining 2.97%, Hong Kong's Hang Seng Index up 0.03%, China's Shanghai Composite surging 1.38%, and India's BSE Sensex falling 0.38% [7] Company News - The U.S. FDA lifted the clinical hold on GH Research Plc's Investigational New Drug Application for GH001 [3] - Momentus Inc shares surged 94% to $11.14 after announcing the development of an additive-manufactured fuel tank [9] - TMD Energy Ltd shares increased by 76% to $0.78 [9] - VerifyMe Inc shares rose 40% to $0.94 following a strategic merger announcement [9] - Zenas Biopharma Inc shares dropped 55% to $15.54 after Phase 3 trial results [9] - Signing Day Sports Inc shares fell 37% to $0.60, and Lavoro Ltd shares decreased by 26% to $0.82 [9]

Market Overview - U.S. stocks traded higher, with the Dow Jones index gaining over 250 points, up 0.54% to 48,641.58, NASDAQ up 0.65% to 23,386.57, and S&P 500 up 0.63% to 6,901.52 [1] - Energy shares increased by 2.9% on Monday [1] Sector Performance - Consumer staples stocks dipped by 0.4% [2] Commodity Prices - Oil traded up 1.4% to $58.12, gold up 2.4% to $4,433.50, silver up 7.5% to $76.320, and copper rose 4.1% to $5.9260 [5] European Market Performance - Eurozone's STOXX 600 gained 0.5%, Spain's IBEX 35 Index rose 0.3%, London's FTSE 100 up 0.4%, Germany's DAX gained 0.2%, and France's CAC 40 climbed 0.1% [6] Asian Market Performance - Asian markets closed mostly higher, with Japan's Nikkei 225 gaining 2.97%, Hong Kong's Hang Seng Index up 0.03%, China's Shanghai Composite surging 1.38%, while India's BSE Sensex fell 0.38% [7] Company News - The FDA lifted the clinical hold on GH Research Plc's Investigational New Drug Application for GH001 [3] - Momentus Inc shares surged 94% to $11.14 after announcing the development of an additive-manufactured fuel tank [9] - TMD Energy Ltd shares increased by 76% to $0.78 [9] - VerifyMe Inc shares rose 40% to $0.94 following a strategic merger announcement [9] - Zenas Biopharma Inc shares dropped 55% to $15.54 after Phase 3 trial results [9] - Signing Day Sports Inc shares fell 37% to $0.60, and Lavoro Ltd shares decreased by 26% to $0.82 [9]

Core Insights - GH Research PLC shares increased by 18.1% to $15.64 in pre-market trading following the announcement of an update on its FDA IND status and Phase 3 program for GH001 in treatment-resistant depression [1] Gainers - MKDWELL Tech Inc surged 61.2% to $0.27 after agreeing to repurchase 34,580,000 ordinary shares at $0.203/share, totaling $7 million [4] - Regencell Bioscience Holdings Ltd gained 52% to $31.21 after a previous decline of 2% [4] - Datavault AI Inc rose 26.7% to $1.28 after a 55% increase on the previous trading day [4] - Sidus Space Inc increased by 21.9% to $5.28 following a 38% rise on Friday [4] - Kazia Therapeutics Ltd rose 21.7% to $6.08 after a 27% decline on Friday [4] - Context Therapeutics Inc gained 18.7% to $1.84 after a 5% increase on Friday [4] - Hyperscale Data Inc rose 18.6% to $0.32 after a 49% jump on Friday [4] - PBF Energy Inc increased by 16.7% to $33.30 after providing updates on Martinez refinery operations and 2026 annual guidance [4] - Bioatla Inc rose 16.1% to $0.62 after a dip of more than 5% on Friday [4] Losers - Salarius Pharmaceuticals Inc fell 21.8% to $0.51 in pre-market trading [4] - Gain Therapeutics Inc decreased by 21.4% to $2.50 [4] - SBC Medical Group Holdings Inc declined 18.9% to $3.51 [4] - Polyrizon Ltd dropped 11.7% to $11.24 after a 50% gain on Friday [4] - ChowChow Cloud International HLDG Ltd dipped 10.3% to $0.71 after a 30% increase on Friday [4] - Lavoro Ltd shares fell 9.1% to $1.00 after a 144% jump on Friday [4] - Vicarious Surgical Inc decreased by 7.9% to $2.32 after a 16% gain on Friday [4] - Theravance Biopharma Inc dipped 6% to $17.07 after a 3% decline on Friday [4] - Comcast Corp tumbled 4.6% to $28.18 [4] - Equinor ASA fell 3.6% to $23.66 after a 4% increase on Friday [4]

Company Overview - Intelligent Bio Solutions Inc. (NASDAQ:INBS) announced plans to raise $10 million through a private placement, leading to a significant drop in its share price [1] - Following the announcement, shares of Intelligent Bio fell 19.7% to $7.65 [1] Stock Movements - Lavoro Limited (NASDAQ:LVRO) saw a substantial increase of 181%, reaching $1.2900 [4] - Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) rose 57.7% to $5.32 after issuing FY26 guidance, expecting US net sales of Linzess to be between $1.125 billion and $1.175 billion [4] - Brand Engagement Network, Inc. (NASDAQ:BNAI) jumped 56% to $3.6290 after entering a Vendor Services Project Agreement with a global advertising agency [4] - ChowChow Cloud International Holdings Limited (NYSE:CHOW) increased by 39.7% to $0.8500 due to year-over-year revenue and net income growth in H1 2025 [4] - Sidus Space, Inc. (NASDAQ:SIDU) gained 29% to $4.0314, marking a 470% surge over the past month [4] - Baidu, Inc. (NASDAQ:BIDU) rose 12.1% to $146.57 after announcing a proposed spin-off and Hong Kong listing of its AI unit [4] Declines - Outlook Therapeutics, Inc. (NASDAQ:OTLK) experienced a significant decline of 58% to $0.6632 after receiving a complete response letter from the FDA regarding its biologics license application [4] - ESH Acquisition Corp. (NASDAQ:ESHA) fell 23.5% to $14.68 [4] - Nuvve Holding Corp. (NASDAQ:NVVE) declined 15.3% to $2.1500 after announcing the closing of a private placement [4]

Group 1 - New Fortress Energy Inc. shares rose 41% to $2.82 in pre-market trading after announcing a long-term gas supply agreement with the Puerto Rican government [1] - The agreement involves the long-term supply of liquefied natural gas to Puerto Rico, reached with the Third-Party Procurement Office and the Puerto Rico Public-Private Partnerships Authority [1] Group 2 - SciSparc Ltd. shares gained 186.2% to $5.27 following a court-granted stay in merger proceedings with AutoMax Motors Ltd. [5] - Educational Development Corporation shares increased by 47.8% to $2.02 after gaining 8% on the previous day [5] - Presidio Property Trust, Inc. shares rose 47.5% to $9.00 after an 8% gain on Tuesday [5] - Oruka Therapeutics, Inc. shares gained 18.6% to $17.68 after disclosing positive interim Phase 1 results and announcing a $180 million private placement [5] - Baidu Inc. shares rose 8.5% to $134.31 after an 8% increase on Tuesday [5] Group 3 - Kindly MD, Inc. shares fell 6.7% to $1.60 as the company will redeem $203 million convertible debenture with a 1.5% payment premium [5] - Co-Diagnostics, Inc. shares dipped 29.2% to $0.4501 after an 80% jump on Tuesday due to a memorandum of understanding with a partner in Saudi Arabia [5] - FGI Industries Ltd. shares declined 25.7% to $7.05 after a 139% increase on Tuesday [5] - Turbo Energy, S.A. shares fell 24.1% to $9.41 after surging 359% on Tuesday due to a $53 million contract for energy storage projects in Spain [5]

Group 1 - Cadiz reported a quarterly loss of $0.14 per share, which was worse than the Zacks Consensus Estimate of a loss of $0.11, and compared to a loss of $0.12 per share a year ago, indicating an earnings surprise of -27.27% [1] - The company posted revenues of $2.95 million for the quarter ended March 2025, missing the Zacks Consensus Estimate by 34.14%, and this represents an increase from year-ago revenues of $1.12 million [2] - Cadiz shares have declined approximately 39% since the beginning of the year, contrasting with the S&P 500's gain of 0.1% [3] Group 2 - The earnings outlook for Cadiz is currently unfavorable, with a Zacks Rank of 4 (Sell), suggesting that the shares are expected to underperform the market in the near future [6] - The current consensus EPS estimate for the upcoming quarter is -$0.09 on revenues of $4.18 million, and for the current fiscal year, it is -$0.05 on revenues of $16.49 million [7] - The Agriculture - Operations industry, to which Cadiz belongs, is currently ranked in the bottom 38% of over 250 Zacks industries, indicating a challenging environment for stock performance [8]

Company Performance - Dole reported quarterly earnings of $0.35 per share, missing the Zacks Consensus Estimate of $0.39 per share, and down from $0.43 per share a year ago, representing an earnings surprise of -10.26% [1] - The company posted revenues of $2.1 billion for the quarter ended March 2025, surpassing the Zacks Consensus Estimate by 4.54%, but down from $2.12 billion year-over-year [2] - Over the last four quarters, Dole has surpassed consensus EPS estimates two times and topped consensus revenue estimates four times [2] Stock Performance - Dole shares have increased approximately 9% since the beginning of the year, contrasting with the S&P 500's decline of -3.8% [3] - The current consensus EPS estimate for the coming quarter is $0.48 on revenues of $2.14 billion, and for the current fiscal year, it is $1.33 on revenues of $8.39 billion [7] Industry Outlook - The Agriculture - Operations industry, to which Dole belongs, is currently in the top 36% of over 250 Zacks industries, indicating a favorable outlook [8] - Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions, suggesting that industry performance can significantly impact stock performance [5][8]

Group 1 - Kenvue reported quarterly earnings of $0.24 per share, exceeding the Zacks Consensus Estimate of $0.22 per share, but down from $0.28 per share a year ago, representing an earnings surprise of 9.09% [1] - The company posted revenues of $3.74 billion for the quarter ended March 2025, surpassing the Zacks Consensus Estimate by 1.70%, but down from $3.89 billion year-over-year [2] - Kenvue has outperformed the S&P 500, with shares increasing about 8.2% since the beginning of the year, while the S&P 500 declined by -4.3% [3] Group 2 - The current consensus EPS estimate for the upcoming quarter is $0.29 on revenues of $3.95 billion, and for the current fiscal year, it is $1.14 on revenues of $15.45 billion [7] - The Zacks Industry Rank indicates that the Consumer Products - Staples sector is in the bottom 28% of over 250 Zacks industries, suggesting potential challenges for stock performance [8]